Drugs alter your mental health by changing how brain cells communicate with each other, particularly in the circuits that regulate mood, motivation, pleasure, and stress. These changes can be temporary or, with heavy or prolonged use, persist for months or years after stopping. About 86.6 million American adults had either a mental illness or a substance use disorder in 2024, and the two frequently overlap in ways that make each condition harder to manage.
How Drugs Hijack Your Brain’s Reward System
Your brain has a built-in reward pathway that releases dopamine, a chemical messenger, whenever you do something beneficial like eating or connecting with other people. This pathway runs from a cluster of neurons deep in the midbrain to areas involved in decision-making and motivation. Drugs of almost every class flood this pathway with dopamine far beyond what any natural reward produces.
Opioids, for example, bind to receptors that suppress the brain’s natural braking system on dopamine release, causing a surge. Stimulants like cocaine and methamphetamine work differently but achieve the same result: abnormally high dopamine levels in the spaces between neurons. Over time, the brain adapts by dialing down its own dopamine production and reducing the number of receptors available to receive it. The practical effect is that everyday activities stop feeling rewarding. Food, hobbies, friendships, and achievements that once brought satisfaction feel flat. This is one of the earliest and most common ways drug use reshapes mental health, and it drives the cycle of needing more of the substance just to feel normal.
Stimulants and Psychosis
Cocaine and methamphetamine carry a significant risk of triggering psychotic symptoms: hallucinations, paranoid delusions, or both. The numbers are striking. Across studies, 60 to 86 percent of people who use cocaine report psychotic symptoms at some point in their lifetime. For methamphetamine, a meta-analysis found that 36.5 percent of people who misuse the drug have experienced psychosis, rising to 43 percent among those with a diagnosed methamphetamine use disorder.
These episodes typically develop during intoxication or within a month of heavy use. For many people, the symptoms resolve once the drug leaves the system. But for some, particularly those with a family history of psychotic disorders, stimulant-induced psychosis can be the first chapter of a longer psychiatric illness. The distinction between a drug-triggered episode and the emergence of an underlying condition like schizophrenia is not always clear-cut, and clinicians often need months of observation to tell the difference.
Alcohol, Depression, and the Serotonin Connection
Alcohol initially produces a calming, mood-lifting effect by boosting the activity of GABA, the brain’s primary “slow down” chemical. That short-term relief is part of what makes it appealing for people dealing with stress or anxiety. Chronic drinking, however, reverses the equation. The brain reduces the number and sensitivity of its GABA receptors to compensate for the constant chemical push, leaving you more anxious and emotionally reactive when sober.
The damage extends to serotonin, the neurotransmitter most closely linked to stable mood. Long-term alcohol use kills serotonin-producing neurons, reduces the density of serotonin transporters in key brain regions, and disrupts the growth of new neurons in the hippocampus, a structure essential for memory and emotional regulation. These changes closely mirror the brain patterns seen in people with major depression who have never had a drinking problem. This is why depression so often accompanies or follows heavy drinking, and why quitting alone does not immediately lift the mood.
Opioids and Your Stress Response
Beyond their effect on the reward system, opioids disrupt the body’s stress management machinery. Your brain, pituitary gland, and adrenal glands form a hormonal loop that calibrates how you respond to threats and recover from them. Chronic opioid use suppresses this loop, reducing the output of key stress hormones. Research comparing opioid-dependent individuals with healthy controls found significantly lower levels of the brain’s primary stress-signaling hormone and abnormal cortisol patterns.
The result is a blunted ability to manage ordinary stress. Small frustrations feel overwhelming, emotional responses become unpredictable, and the capacity to self-soothe without the drug erodes. During withdrawal, the system overcorrects: stress hormones spike, the adrenal glands become hyperactive, and the experience of anxiety and emotional distress intensifies well beyond what the original stressor would normally produce. This dysregulation is a major reason why people in early recovery from opioids feel emotionally fragile for weeks or months.
Cannabis and Schizophrenia Risk
Cannabis is often perceived as low-risk, but its relationship with psychotic disorders is well established. A pooled analysis of epidemiological studies found that cannabis use roughly triples the overall risk of developing schizophrenia or schizophrenia-like symptoms, with an odds ratio of 2.88. The risk climbs dramatically for people who begin using during adolescence. Two studies focusing specifically on teenage use found odds ratios of 26.7 and 6.5, meaning the risk increase for young users may be many times higher than for adults who start later.
This does not mean every adolescent who tries cannabis will develop schizophrenia. The baseline risk is low, so even a large multiplier still results in a relatively small absolute number. But for individuals who carry genetic vulnerability, regular cannabis use during the teenage years appears to act as a trigger, pulling forward a condition that might otherwise have remained dormant or never appeared at all.
Why the Adolescent Brain Is More Vulnerable
The brain is not fully developed until the mid-20s. During adolescence, it is actively pruning unused neural connections and strengthening the ones it needs, particularly in areas responsible for impulse control, judgment, and emotional regulation. Introducing drugs during this window interferes with that remodeling process in ways that have lasting consequences.
Large cohort studies have linked adolescent alcohol, cannabis, and other drug use to an increased risk of depression, substance use disorders, and suicidal behavior later in life. Both cannabis and other drug use during the teenage years are specifically associated with later depression and further substance problems. These are not just correlations driven by troubled kids seeking out drugs. The developing brain is physically more susceptible to the neurochemical disruptions that drugs cause, and the damage to still-forming circuits can alter the trajectory of mental health into adulthood.
Post-Acute Withdrawal and Lingering Symptoms
Most people expect withdrawal to be a short, intense ordeal. The acute phase is. But a second wave of symptoms, often called post-acute withdrawal syndrome (PAWS), can stretch for months. This phase involves predominantly negative emotional states: anxiety, depression, irritability, inability to feel pleasure, trouble sleeping, difficulty concentrating, and persistent cravings. These symptoms peak in severity during the first four to six months of abstinence and gradually diminish, though mood and anxiety symptoms have been documented up to several years after stopping.
The timeline varies by symptom. The inability to feel pleasure tends to be most severe in the first 30 days. Cravings hit hardest in the first three weeks. Sleep problems can persist for roughly six months. Cognitive difficulties, such as trouble with memory and focus, typically clear within a few months but can leave residual effects for up to a year. This protracted withdrawal has been most consistently described for alcohol and opioids, with some evidence for benzodiazepines as well.
Understanding PAWS matters because many people in early recovery interpret these symptoms as evidence that they are fundamentally broken or that sobriety is not working. In reality, the brain is recalibrating systems that were thrown off balance, and the discomfort is a sign of that process, not a permanent state.
Hallucinogens and Lasting Perceptual Changes
A small number of people who use hallucinogens like LSD or psilocybin develop a condition in which visual disturbances from the drug experience recur long after the substance has left their body. These can include trails behind moving objects, halos around lights, flickering in peripheral vision, or geometric patterns. The condition comes in two forms. The milder version involves brief, infrequent flashbacks that are more odd than distressing. The more severe form is persistent, sometimes irreversible, and can cause significant anxiety and impairment in daily life.
The condition is rare, and its exact prevalence is unknown. Researchers believe it may involve a lasting over-activation of neural visual pathways that worsens anxiety in predisposed individuals. Notably, it has been reported after use of non-hallucinogenic substances as well, suggesting that individual vulnerability plays a significant role.
How the Brain Recovers After Stopping
The brain has a remarkable capacity to repair itself once substance use stops. Neuroimaging studies tracking people through abstinence show structural recovery in the frontal cortex (the region most critical for decision-making and impulse control), the hippocampus (memory), and the cerebellum (coordination). For people recovering from alcohol use disorder, the majority of gray matter volume recovery occurs within the first month of abstinence, which is faster than many people expect.
Structural recovery tends to come first. The brain’s chemistry takes longer to normalize, and the restoration of full cognitive and emotional function may require the longest timeline. This staggered recovery explains why someone might look healthier and think more clearly relatively early in sobriety but still struggle with motivation, emotional reactivity, or pleasure for months afterward. The trajectory is encouraging, though: each month of sustained abstinence typically brings measurable improvement, and the steepest gains happen in the first year.